![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
In Silico Pharmacokinetic/Pharmacodynamic Simulation Of
Long Acting Tenofovir Injectable Formulation For Pre-exposure Prophylaxis Strategies
|
|
|
Reported by Jules Levin
17th International Workshop on Clinical Pharmacology of HIV and Hepatitis Therapy, 8-10 June 2016, Washington, DC, USA
Paul Curley, Darren Moss, Rajith K R Rajoli, James Hobson, Caren L. Freel Meyers,
Charles Flexner, Steve Rannard, Andrew Owen and Marco Siccard i
![Clin1](../images/062216/062216-7/Clin1.gif)
![Clin2](../images/062216/062216-7/Clin2.gif)
![Clin3](../images/062216/062216-7/Clin3.gif)
![Clin4](../images/062216/062216-7/Clin4.gif)
![Clin5](../images/062216/062216-7/Clin5.gif)
![Clin6](../images/062216/062216-7/Clin6.gif)
![Clin7](../images/062216/062216-7/Clin7.gif)
![Clin8](../images/062216/062216-7/Clin8.gif)
![Clin9](../images/062216/062216-7/Clin9.gif)
![Clin10](../images/062216/062216-7/Clin10.gif)
![Clin11](../images/062216/062216-7/Clin11.gif)
![Clin12](../images/062216/062216-7/Clin12.gif)
![Clin13](../images/062216/062216-7/Clin13.gif)
![Clin14](../images/062216/062216-7/Clin14.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|